MedPath
NMPA Approval

Riluzole Tablets

H20140172

June 24, 2020

H20140172

Drug Information

利鲁唑片

力如太

片剂

50mg

化学药品

June 24, 2020

November 29, 2023

Company Information

Applicant Company

SANOFI MATURE IP

54, rue La Boétie, 75008 Paris, France

Manufacturing Company

56 Route de Choisy au Bac, F-60205 Compiegne, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

利鲁唑片 - NMPA 批准文号 | MedPath